1. Home
  2. Didier Breyer
  3. Didier Breyer

Primary tabs

Search
Limit to
Export 25 results:
Filters: Author is Didier Breyer
2019
Opinion: Airtightness for Decontamination by Fumigation of High-Containment Laboratories, Coppens, Fanny, Willemarck Nicolas, and Breyer Didier , Applied Biosafety, 2019-08-27, (2019)
SPECENZYM : A project to study the purity of food enzymes, Deckers, Marie, Vanneste Kevin, Denayer Sarah, De Keersmaecker Sigrid C. J., Heyndrickx M, De Loose M, Berben G, Debode F, Papazova N., Fox P, et al. , 2019, (2019)
2018
Risk Classification of Zoonotic Microorganisms: Development of a One Health Approach Tool Applied to HPAI A H5N1 Viruses, Baldo, Aline, Welby Sarah, Do Thi Chuong Dai, Leunda Amaya, Herman Philippe, and Breyer Didier , Applied Biosafety, Jan-09-2020, (2018)
2016
Field trials with GM trees: a step-by-step approach, Glandorf, D. C. M., and Breyer Didier , Biosafety of forest transgenic trees - improving the scientific basis for safe tree development and implementation of EU policy directives, 0/0/2016, Volume 82, Issue 7, Number 154, Dordrecht, p.342, (2016)
2014
Alternatives to antibiotic resistance marker genes for in vitro selection of genetically modified plants - Scientific developments, current use, operational access and biosafety considerations, Breyer, Didier, Kopertekh L., and Reheul D. , Critical Reviews in Plant Sciences, 0/0/2014, Volume 33, Issue 4, Number 330, p.286 - 330, (2014)
Engineering nucleases for gene targeting: safety and regulatory considerations., Pauwels, Katia, Podevin Nancy, Breyer Didier, Carroll Dana, and Herman Philippe , N Biotechnol, 2014 Jan 25, Volume 31, Issue 1, Number 27, p.18-27, (2014)
2013
Biosafety risk assessment and management of laboratory-derived influenza A (H5N1) viruses transmissible in ferrets, Baldo, Aline, Leunda Amaya, Do Thi Chuong Dai, Breyer Didier, Pauwels Katia, Welby Sarah, Van Vaerenbergh Bernadette, and Herman Philippe , Applied Biosafety, 3/2013, Volume 18, Issue 1, Number 17, (2013)
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors., Goossens, Martine, Pauwels Katia, Willemarck Nicolas, and Breyer Didier , Curr Gene Ther, 2013 Dec, Volume 13, Issue 6, p.413-20, (2013)
Event report: SynBio Workshop (Paris 2012) - Risk assessment challenges of Synthetic Biology, Pauwels, Katia, Mampuys Ruth, Golstein Catherine, Breyer Didier, Herman Philippe, Kaspari M., Pagès J-C., Pfister Herbert, and Wilk Frank , J.Verbr.Lebensm., 0/0/2013, Volume 8, Number 226, p.215 - 226, (2013)
2012
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination., Verheust, Céline, Goossens Martine, Pauwels Katia, and Breyer Didier , Vaccine, 2012 Mar 30, Volume 30, Issue 16, p.2623-32, (2012)
Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges, Pauwels, Katia, Willemarck Nicolas, Breyer Didier, and Herman Philippe , 0/0/2012, Number 43, Brussels, Belgium, p.43, (2012)
2010
De Europese regelgeving inzake GGO's in het licht van nieuwe technieken van genetische modificatie2769, Pauwels, Katia, Breyer Didier, and Herman Philippe , ILVO Nieuwsgolf, 0/0/2010, Volume Sept 2010, (2010)
New techniques of genetic modification and the GMO definition, Breyer, Didier, Pauwels Katia, and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 146, Brussels, p.144 - 146, (2010)
2009
Biosafety in Biotechnology, Collard, J-M, Breyer Didier, Renckens S., Sneyers Myriam, Van Haver E., Van Vaerenbergh Bernadette, and Moens William , Biotechnology - Vol I: Biosafety in Biotechnoogy, 0/0/2009, Number 22, Oxford, UK, p.-, (2009)
Co-Extra: Europees project over co-existentie en traceerbaarheid van GGO en niet-GGO productieketens, Breyer, Didier, Roosens Nancy, Berben G., Taverniers Isabel, Van den Bulcke Marc, and Sneyers Myriam , LabInfo, 0/0/2009, Volume 3, Issue November 2009, Number 23, p.22 - 23, (2009)
Co-Extra: Projet européen sur la coexistence et la traçabilité des filières OGM et non-OGM, Breyer, Didier, Roosens Nancy, Berben G., Taverniers Isabel, Van den Bulcke Marc, and Sneyers Myriam , LabInfo, 0/0/2009, Volume 3, Issue Novembre 2009, Number 23, p.22 - 23, (2009)
European project Co-Extra: GM and non-GM supply chains: their co-existence and traceability, Breyer, Didier, Roosens Nancy, Berben G., Taverniers Isabel, Van den Bulcke Marc, and Sneyers Myriam , LabInfo, 1/11/2009, Volume 3, Number 23, Brussels, p.22 - 23, (2009)
Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?, Breyer, Didier, Herman Philippe, Brandenburger Annick, Gheysen Godelieve, Remaut Erik, Soumillion Patrice, Van Doorsselaere Jan, Custers René, Pauwels Katia, Sneyers Myriam, et al. , Environ Biosafety Res, 2009 Apr-Jun, Volume 8, Issue 2, p.57-64, (2009)
Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation, Breyer, Didier, Herman Philippe, Brandenburger A., Gheysen G., Remaut E., Soumillion P., Van Doorsselaere J., Custers R., Pauwels Katia, Sneyers Myriam, et al. , ISB news report, 0/0/2009, Volume November 2009, Number 12, Brussels, p.2 - 12, (2009)
2007
Bringing scientists to the people--the Co-Extra website., Breyer, Didier, Daubresse Pierre, and Sneyers Myriam , Biotechnol J, 2007 Sep, Volume 2, Issue 9, p.1081-5, (2007)
2006
Biosafety recommendations for the contained use of Mycobacterium tuberculosis complex isolates in industrialized countries, Herman, Philippe, Fauville M., Breyer Didier, Van Vaerenbergh Bernadette, Pauwels Katia, Do Thi Chuong Dai, Sneyers Myriam, Wanlin M., Snacken R., and Moens William , 0/0/2006, Volume D/2006/2505/22, Number 17, Brussels, p.17, (2006)
2004
Biosafety risk assessment of the Severe Acute Respiratory Syndrome (SARS) coronavirus and containment measures for the diagnostic and research laboratories, Herman, Philippe, Verlinden Y., Breyer Didier, Van Cleemput E., Brochier Bernard, Sneyers Myriam, Snacken R., Hermans P., Kerkhofs Pierre, Liesnard C., et al. , Appl.Biosaf., 0/0/2004, Volume 9, Issue 3, Number 142, p.128 - 142, (2004)
2000
Le protocole sur la biosécurité: test de crédibilité pour l'avenir de la Convention sur la diversité biologique?, Breyer, Didier, and Moens William , Bull.Institut.Roy.Sci.Natur.Belg., 0/0/2000, Volume 70, Issue Suppl, Number 52, p.45 - 52, (2000)
1997
Manipulation d'organismes pathogènes ou génétiquement modifiés dans les hôpitaux, Collard, J-M, Breyer Didier, Sneyers Myriam, Van Vaerenbergh Bernadette, and Moens William , Het Belgisch Ziekenhuis, 0/0/1997, Volume 4, Number 62, p.55 - 62, (1997)
0
Gestion des déchets biologiquement contaminés produits lors des activités d'utilisation confinée d'organismes génétiquement modifiés et/ou pathogènes - Lignes directrices et recommandations, Baldo, Aline, Descamps Emilie, Do Thi Chuong Dai, Leunda Amaya, Willemarck Nicolas, and Breyer Didier , (0)

QR code

QR code for this page URL